Clinical Observation on Treatment of Heart Rate Variability of Blood Stasis of Ischemic Cardio-cerebral Vascular Diseases with Chinese Medicine Oral Fluid
Guo Jian,Liu Qin,Li Guoxian
DOI: https://doi.org/10.3969/j.issn.1673-6613.2007.12.009
2007-01-01
Abstract:Objective:To probe the therapeutic effect and safety of Chinese medicines for heart rate variability of blood stasis of ischemic cardio-cerebral vascular diseases.Methods:The method of evidence-based medicine (EBM) was adopted.The 185 patients were randomized into Group A,B,C,D,and E and administered Kangshuan (anti-embolus) 1,2,3,4,and 5 Oral Fluid respectively for 3 months.Results:In relieving angina pectoris and in the aspects of transcranial doppler (TCD),electrocardiogram (ECG),blood stasis,hemorheology,and brain image,the total effective rate of Group A,B and C was obviously better than that of Group D and E (P<0.01 or P<0.001),and there was no significant difference among GroupA,B and C.Conclusion:For the heart rate variability of blood stasis of ischemic cardio-cerebral vascular diseases,the effect of Group A (Jiangyi No.14),Group C (Jiangyi No.2),and Group B (Linaoxin Capsule,the medicine for comparison) is the best,Group D (Jiangyi No.37) takes second place,and Group E (placebo,Erchen Tang) is the last (P<0.05～0.001).All of them are safe,without toxicity.